Report: BioJapan 2022 and Regenerative Medicine JAPAN 2022

FIRM exhibited at BioJapan/R​egenerativ​e​ Medicine JAPAN2022 held on-line with Pacifico Yokohama on October 12-14 this year as well.  We would like to express our sincere gratitude for the many visitors.  Panels of Supporting Industries Committee, Cell and Gene Therapy Products Committee, and Specific Processed Cells Committee were displayed in the FIRM booth. These three committees and the Public Relations Committee assigned briefings there.

Title: Challenges and actual conditions for ecosystems in regenerative medicine – focusing on the manufacturing of regenerative medicine

Experts were invited to discuss how the manufacturing ecosystem for regenerative medicine should be aimed by Japan.

Title: Towards universalization of regenerative medicine (cell therapy, gene therapy)-Challenges to diversity

In order to universalize regenerative medicine, we introduced the government’s ideas on research and human resource development, the possibility of using data, including post-marketing, and the introduction of a system adapted to the diverse nature, and conducted discussions between experts from various fields and product companies.

Title: Latest trends in regenerative medicine and other products

As of September 2022, 17 regenerative medicine products have been approved.  we presented the recently approved regenerative medicine and other products, and how they will be marketed and developed in the future.